Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation.
A AlbayBahar Artim EsenC PericleousChris WincupI GilesA RahmanThomas C R McDonnellPublished in: Lupus (2019)
Inhibition of IgA aβ2GPI by DI is possible and can be enhanced by biochemical modification in a subset of patients.